Structure

Physi-Chem Properties

Molecular Weight:  308.24
Volume:  347.085
LogP:  5.96
LogD:  4.015
LogS:  -4.457
# Rotatable Bonds:  12
TPSA:  46.53
# H-Bond Aceptor:  3
# H-Bond Donor:  1
# Rings:  1
# Heavy Atoms:  3

MedChem Properties

QED Drug-Likeness Score:  0.312
Synthetic Accessibility Score:  3.35
Fsp3:  0.737
Lipinski Rule-of-5:  Accepted
Pfizer Rule:  Rejected
GSK Rule:  Rejected
BMS Rule:  1
Golden Triangle Rule:  Accepted
Chelating Alert:  0
PAINS Alert:  0

ADMET Properties (ADMETlab2.0)

ADMET: Absorption

Caco-2 Permeability:  -4.923
MDCK Permeability:  2.5098166588577442e-05
Pgp-inhibitor:  0.006
Pgp-substrate:  0.01
Human Intestinal Absorption (HIA):  0.009
20% Bioavailability (F20%):  0.999
30% Bioavailability (F30%):  0.999

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):  0.924
Plasma Protein Binding (PPB):  97.4166488647461%
Volume Distribution (VD):  0.893
Pgp-substrate:  1.7446478605270386%

ADMET: Metabolism

CYP1A2-inhibitor:  0.384
CYP1A2-substrate:  0.164
CYP2C19-inhibitor:  0.552
CYP2C19-substrate:  0.06
CYP2C9-inhibitor:  0.306
CYP2C9-substrate:  0.835
CYP2D6-inhibitor:  0.018
CYP2D6-substrate:  0.059
CYP3A4-inhibitor:  0.325
CYP3A4-substrate:  0.104

ADMET: Excretion

Clearance (CL):  5.263
Half-life (T1/2):  0.148

ADMET: Toxicity

hERG Blockers:  0.007
Human Hepatotoxicity (H-HT):  0.033
Drug-inuced Liver Injury (DILI):  0.284
AMES Toxicity:  0.035
Rat Oral Acute Toxicity:  0.554
Maximum Recommended Daily Dose:  0.988
Skin Sensitization:  0.979
Carcinogencity:  0.575
Eye Corrosion:  0.988
Eye Irritation:  0.975
Respiratory Toxicity:  0.977

Download Data

Data Type Select
General Info & Identifiers & Properties  
Structure MOL file  
Source Organisms  
Biological Activities  
Similar NPs/Drugs  

  Natural Product: NPC5180

Natural Product ID:  NPC5180
Common Name*:   Nimbolide
IUPAC Name:   n.a.
Synonyms:   Nimbolide
Standard InCHIKey:  JZIQWNPPBKFOPT-LSYMHUITSA-N
Standard InCHI:  InChI=1S/C27H30O7/c1-13-15(14-7-9-32-12-14)10-16-20(13)27(4)17(11-19(29)31-5)26(3)18(28)6-8-25(2)22(26)21(23(27)33-16)34-24(25)30/h6-9,12,15-17,21-23H,10-11H2,1-5H3/t15-,16-,17-,21-,22+,23-,25-,26+,27-/m1/s1
SMILES:  COC(=O)C[C@H]1[C@@]2(C)[C@H](O[C@H]3C2=C(C)[C@@H](C3)c2cocc2)[C@H]2[C@@H]3[C@]1(C)C(=O)C=C[C@@]3(C)C(=O)O2
Synthetic Gene Cluster:   n.a.
ChEMBL Identifier:   CHEMBL426690
PubChem CID:   12313376
Chemical Classification**:  
  • CHEMONTID:0000000 [Organic compounds]
    • [CHEMONTID:0000012] Lipids and lipid-like molecules
      • [CHEMONTID:0000259] Prenol lipids
        • [CHEMONTID:0001553] Triterpenoids
          • [CHEMONTID:0002380] Limonoids

*Note: the InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
**Note: the Chemical Classification was calculated by NPClassifier Version 1.5. Reference: PMID:34662515.

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO4406 Azadirachta indica Species Meliaceae Eukaryota n.a. n.a. n.a. PMID[12193038]
NPO4406 Azadirachta indica Species Meliaceae Eukaryota n.a. n.a. n.a. PMID[1593280]
NPO4406 Azadirachta indica Species Meliaceae Eukaryota n.a. n.a. n.a. PMID[18816111]
NPO4406 Azadirachta indica Species Meliaceae Eukaryota n.a. n.a. n.a. PMID[19299148]
NPO4406 Azadirachta indica Species Meliaceae Eukaryota fruits n.a. n.a. PMID[20669933]
NPO4406 Azadirachta indica Species Meliaceae Eukaryota Seeds n.a. n.a. PMID[21381696]
NPO4406 Azadirachta indica Species Meliaceae Eukaryota n.a. seed n.a. PMID[21381696]
NPO4406 Azadirachta indica Species Meliaceae Eukaryota n.a. n.a. n.a. PMID[2607354]
NPO4406 Azadirachta indica Species Meliaceae Eukaryota n.a. n.a. n.a. PMID[2614419]
NPO4406 Azadirachta indica Species Meliaceae Eukaryota n.a. n.a. n.a. PMID[26339153]
NPO4406 Azadirachta indica Species Meliaceae Eukaryota Leaves n.a. n.a. PMID[28493718]
NPO4406 Azadirachta indica Species Meliaceae Eukaryota n.a. fruit n.a. PMID[9134742]
NPO4406 Azadirachta indica Species Meliaceae Eukaryota n.a. leaf n.a. PMID[9134742]
NPO4406 Azadirachta indica Species Meliaceae Eukaryota n.a. bark n.a. PMID[9134742]
NPO4406 Azadirachta indica Species Meliaceae Eukaryota n.a. n.a. n.a. Database[UNPD]

☑ Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  NP Quantity Composition/Concentration

Organism ID NP ID Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

☑ Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  Biological Activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT382 Cell Line OVCAR-5 Homo sapiens IC50 = 4170.0 nM PMID[520781]
NPT306 Cell Line PC-3 Homo sapiens IC50 = 4590.0 nM PMID[520781]
NPT81 Cell Line A549 Homo sapiens IC50 = 15560.0 nM PMID[520781]
NPT379 Cell Line HOP-62 Homo sapiens IC50 = 10370.0 nM PMID[520781]
NPT6349 Cell Line SW-60 Homo sapiens IC50 = 8250.0 nM PMID[520781]
NPT139 Cell Line HT-29 Homo sapiens IC50 = 6940.0 nM PMID[520781]
NPT1851 Cell Line Col2 Homo sapiens ED50 = 0.41 ug ml-1 PMID[520783]
NPT453 Cell Line HT-1080 Homo sapiens ED50 = 0.31 ug ml-1 PMID[520783]
NPT1034 Cell Line Lu1 Homo sapiens ED50 = 0.42 ug ml-1 PMID[520783]
NPT147 Cell Line SK-MEL-2 Homo sapiens ED50 = 0.53 ug ml-1 PMID[520783]
NPT91 Cell Line KB Homo sapiens ED50 = 0.25 ug ml-1 PMID[520783]
NPT168 Cell Line P388 Mus musculus ED50 = 0.065 ug ml-1 PMID[520783]
NPT82 Cell Line MDA-MB-231 Homo sapiens IC50 = 6000.0 nM PMID[520786]
NPT83 Cell Line MCF7 Homo sapiens IC50 = 4000.0 nM PMID[520786]
NPT6 Organism Plasmodium falciparum Plasmodium falciparum IC50 = 1.74 ug.mL-1 PMID[520782]
NPT20529 NON-MOLECULAR NON-PROTEIN TARGET n.a. ED50 = 0.39 ug ml-1 PMID[520783]
NPT485 Organism Plasmodium falciparum (isolate K1 / Thailand) Plasmodium falciparum K1 EC50 = 0.00095 ug.mL-1 PMID[520784]
NPT1175 Organism Spodoptera litura Spodoptera litura AFI = 37.0 % PMID[520785]
NPT27 Others Unspecified Cmax = 0.0153 ug.mL-1 PMID[520786]
NPT27 Others Unspecified Cmax = 5.555 ug.mL-1 PMID[520786]

☑ Note for Activity Records:
☉ The quantitative biological activities were primarily integrated from ChEMBL (Version-30) database and were also directly collected from PubMed literature. PubMed PMID was provided as the reference link for each activity record.

  Chemically structural similarity: I. Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes 4,3285 NPs with experimentally-derived bioactivity available in NPASS)

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient

●  The left chart: Distribution of similarity level between NPC5180 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).

Similarity Score Similarity Level Natural Product ID
0.993 High Similarity NPC291150
0.9655 High Similarity NPC116717
0.9384 High Similarity NPC471001
0.9333 High Similarity NPC197137
0.9195 High Similarity NPC322546
0.9195 High Similarity NPC308205
0.9195 High Similarity NPC471002
0.9178 High Similarity NPC470999
0.911 High Similarity NPC34056
0.9079 High Similarity NPC470118
0.9073 High Similarity NPC296807
0.9073 High Similarity NPC141538
0.9073 High Similarity NPC155939
0.9 High Similarity NPC471000
0.8954 High Similarity NPC214495
0.8954 High Similarity NPC469847
0.8954 High Similarity NPC470119
0.8947 High Similarity NPC92979
0.894 High Similarity NPC29695
0.894 High Similarity NPC182427
0.8912 High Similarity NPC199044
0.8912 High Similarity NPC238843
0.8816 High Similarity NPC470996
0.8808 High Similarity NPC196846
0.8792 High Similarity NPC471292
0.8782 High Similarity NPC471003
0.8774 High Similarity NPC475226
0.8767 High Similarity NPC56197
0.875 High Similarity NPC272590
0.875 High Similarity NPC285227
0.8742 High Similarity NPC234494
0.8733 High Similarity NPC471174
0.8726 High Similarity NPC471168
0.8718 High Similarity NPC191828
0.8716 High Similarity NPC223415
0.8716 High Similarity NPC470741
0.871 High Similarity NPC475066
0.8671 High Similarity NPC61967
0.8658 High Similarity NPC251865
0.8654 High Similarity NPC472671
0.8627 High Similarity NPC18135
0.8618 High Similarity NPC195325
0.8609 High Similarity NPC71821
0.8609 High Similarity NPC216755
0.8609 High Similarity NPC302987
0.8581 High Similarity NPC20500
0.8581 High Similarity NPC471175
0.8571 High Similarity NPC33938
0.8571 High Similarity NPC268905
0.8571 High Similarity NPC246164
0.8562 High Similarity NPC469335
0.8562 High Similarity NPC156189
0.8562 High Similarity NPC159927
0.8562 High Similarity NPC470997
0.8544 High Similarity NPC471166
0.8544 High Similarity NPC471167
0.8544 High Similarity NPC470792
0.8531 High Similarity NPC298190
0.8526 High Similarity NPC175964
0.8526 High Similarity NPC471169
0.8516 High Similarity NPC34421
0.8516 High Similarity NPC237259
0.8516 High Similarity NPC98206
0.8497 Intermediate Similarity NPC472654
0.8487 Intermediate Similarity NPC221809
0.8487 Intermediate Similarity NPC255414
0.8477 Intermediate Similarity NPC185456
0.8471 Intermediate Similarity NPC167142
0.8471 Intermediate Similarity NPC472283
0.8467 Intermediate Similarity NPC80635
0.8466 Intermediate Similarity NPC469848
0.8462 Intermediate Similarity NPC44675
0.8462 Intermediate Similarity NPC264943
0.8462 Intermediate Similarity NPC214541
0.8452 Intermediate Similarity NPC75906
0.8446 Intermediate Similarity NPC90953
0.8442 Intermediate Similarity NPC196864
0.8442 Intermediate Similarity NPC477404
0.8438 Intermediate Similarity NPC126984
0.8438 Intermediate Similarity NPC27541
0.8438 Intermediate Similarity NPC62692
0.8431 Intermediate Similarity NPC471007
0.8428 Intermediate Similarity NPC197596
0.8428 Intermediate Similarity NPC472668
0.8418 Intermediate Similarity NPC84349
0.8414 Intermediate Similarity NPC471006
0.8408 Intermediate Similarity NPC204663
0.8408 Intermediate Similarity NPC60973
0.84 Intermediate Similarity NPC121158
0.8397 Intermediate Similarity NPC178932
0.8385 Intermediate Similarity NPC307781
0.8385 Intermediate Similarity NPC472670
0.8378 Intermediate Similarity NPC236532
0.8377 Intermediate Similarity NPC69647
0.8377 Intermediate Similarity NPC470791
0.8377 Intermediate Similarity NPC470790
0.8377 Intermediate Similarity NPC125182
0.8375 Intermediate Similarity NPC285567
0.8375 Intermediate Similarity NPC419
0.8375 Intermediate Similarity NPC224394
0.8375 Intermediate Similarity NPC283209
0.8375 Intermediate Similarity NPC663
0.8375 Intermediate Similarity NPC292389
0.8375 Intermediate Similarity NPC472669
0.8375 Intermediate Similarity NPC469338
0.8367 Intermediate Similarity NPC146872
0.8365 Intermediate Similarity NPC287559
0.8365 Intermediate Similarity NPC305016
0.8354 Intermediate Similarity NPC472778
0.8354 Intermediate Similarity NPC299038
0.8354 Intermediate Similarity NPC472777
0.8354 Intermediate Similarity NPC195131
0.8354 Intermediate Similarity NPC472776
0.8354 Intermediate Similarity NPC261597
0.8344 Intermediate Similarity NPC469850
0.8344 Intermediate Similarity NPC469336
0.8344 Intermediate Similarity NPC25351
0.8333 Intermediate Similarity NPC476201
0.8333 Intermediate Similarity NPC294511
0.8333 Intermediate Similarity NPC476224
0.8333 Intermediate Similarity NPC472672
0.8333 Intermediate Similarity NPC121615
0.8333 Intermediate Similarity NPC472764
0.8323 Intermediate Similarity NPC470940
0.8323 Intermediate Similarity NPC476936
0.8323 Intermediate Similarity NPC228842
0.8323 Intermediate Similarity NPC469849
0.8323 Intermediate Similarity NPC276551
0.8313 Intermediate Similarity NPC5741
0.8313 Intermediate Similarity NPC18986
0.8313 Intermediate Similarity NPC478177
0.8313 Intermediate Similarity NPC472771
0.8313 Intermediate Similarity NPC69028
0.8311 Intermediate Similarity NPC470742
0.8302 Intermediate Similarity NPC474932
0.8302 Intermediate Similarity NPC477403
0.8302 Intermediate Similarity NPC475967
0.8293 Intermediate Similarity NPC475641
0.8293 Intermediate Similarity NPC475237
0.8291 Intermediate Similarity NPC209364
0.8291 Intermediate Similarity NPC104736
0.8291 Intermediate Similarity NPC263265
0.8282 Intermediate Similarity NPC472766
0.8282 Intermediate Similarity NPC472765
0.8282 Intermediate Similarity NPC327922
0.828 Intermediate Similarity NPC302054
0.828 Intermediate Similarity NPC57998
0.828 Intermediate Similarity NPC253201
0.8278 Intermediate Similarity NPC473152
0.8272 Intermediate Similarity NPC472141
0.8272 Intermediate Similarity NPC470875
0.8267 Intermediate Similarity NPC148374
0.8261 Intermediate Similarity NPC476197
0.8261 Intermediate Similarity NPC472773
0.8261 Intermediate Similarity NPC165218
0.8258 Intermediate Similarity NPC470998
0.825 Intermediate Similarity NPC477402
0.8247 Intermediate Similarity NPC250228
0.8239 Intermediate Similarity NPC286722
0.8239 Intermediate Similarity NPC187149
0.8239 Intermediate Similarity NPC36655
0.8239 Intermediate Similarity NPC304692
0.8235 Intermediate Similarity NPC56731
0.8232 Intermediate Similarity NPC118086
0.8228 Intermediate Similarity NPC476262
0.8224 Intermediate Similarity NPC267632
0.8224 Intermediate Similarity NPC243577
0.8221 Intermediate Similarity NPC478179
0.8221 Intermediate Similarity NPC476850
0.8221 Intermediate Similarity NPC173516
0.8221 Intermediate Similarity NPC476861
0.8219 Intermediate Similarity NPC471817
0.8217 Intermediate Similarity NPC84063
0.821 Intermediate Similarity NPC123088
0.8199 Intermediate Similarity NPC470939
0.8199 Intermediate Similarity NPC6326
0.8199 Intermediate Similarity NPC472767
0.8199 Intermediate Similarity NPC329938
0.8199 Intermediate Similarity NPC68848
0.8193 Intermediate Similarity NPC94763
0.8193 Intermediate Similarity NPC236004
0.8188 Intermediate Similarity NPC310043
0.8188 Intermediate Similarity NPC310830
0.8187 Intermediate Similarity NPC307383
0.8187 Intermediate Similarity NPC475295
0.8187 Intermediate Similarity NPC473473
0.8187 Intermediate Similarity NPC237155
0.8182 Intermediate Similarity NPC346
0.8182 Intermediate Similarity NPC262198
0.8176 Intermediate Similarity NPC92941
0.8176 Intermediate Similarity NPC469485
0.8176 Intermediate Similarity NPC242068
0.8176 Intermediate Similarity NPC158525
0.8176 Intermediate Similarity NPC107646
0.8176 Intermediate Similarity NPC247563
0.8171 Intermediate Similarity NPC472673
0.8171 Intermediate Similarity NPC471397
0.817 Intermediate Similarity NPC142113
0.817 Intermediate Similarity NPC84479
0.8165 Intermediate Similarity NPC30222

  Chemically structural similarity: II. Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC5180 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
0.7914 Intermediate Similarity NPD5537 Clinical (unspecified phase)
0.7888 Intermediate Similarity NPD5760 Phase 2
0.7888 Intermediate Similarity NPD5761 Phase 2
0.7719 Intermediate Similarity NPD6764 Approved
0.7719 Intermediate Similarity NPD6765 Approved
0.76 Intermediate Similarity NPD8434 Phase 2
0.7543 Intermediate Similarity NPD6785 Approved
0.7543 Intermediate Similarity NPD6784 Approved
0.7358 Intermediate Similarity NPD4628 Phase 3
0.717 Intermediate Similarity NPD1471 Phase 3
0.7091 Intermediate Similarity NPD920 Approved
0.7081 Intermediate Similarity NPD7421 Clinical (unspecified phase)
0.7076 Intermediate Similarity NPD919 Approved
0.7063 Intermediate Similarity NPD2343 Clinical (unspecified phase)
0.703 Intermediate Similarity NPD6273 Approved
0.6994 Remote Similarity NPD1247 Approved
0.6989 Remote Similarity NPD7893 Clinical (unspecified phase)
0.697 Remote Similarity NPD642 Clinical (unspecified phase)
0.6964 Remote Similarity NPD6599 Discontinued
0.6951 Remote Similarity NPD643 Clinical (unspecified phase)
0.6936 Remote Similarity NPD5494 Approved
0.6805 Remote Similarity NPD3226 Approved
0.68 Remote Similarity NPD8127 Discontinued
0.6789 Remote Similarity NPD4107 Approved
0.6768 Remote Similarity NPD1243 Approved
0.6744 Remote Similarity NPD7819 Suspended
0.6744 Remote Similarity NPD7096 Clinical (unspecified phase)
0.673 Remote Similarity NPD8032 Phase 2
0.6728 Remote Similarity NPD3748 Approved
0.6728 Remote Similarity NPD2799 Discontinued
0.6711 Remote Similarity NPD17 Approved
0.6707 Remote Similarity NPD6799 Approved
0.6706 Remote Similarity NPD7458 Discontinued
0.6688 Remote Similarity NPD3972 Approved
0.6687 Remote Similarity NPD2796 Approved
0.6686 Remote Similarity NPD6980 Clinical (unspecified phase)
0.6685 Remote Similarity NPD8055 Clinical (unspecified phase)
0.6667 Remote Similarity NPD4482 Phase 3
0.6667 Remote Similarity NPD6808 Phase 2
0.6667 Remote Similarity NPD7004 Clinical (unspecified phase)
0.6667 Remote Similarity NPD5844 Phase 1
0.6648 Remote Similarity NPD6559 Discontinued
0.6646 Remote Similarity NPD6005 Phase 3
0.6646 Remote Similarity NPD6003 Clinical (unspecified phase)
0.6646 Remote Similarity NPD6004 Phase 3
0.6646 Remote Similarity NPD6006 Clinical (unspecified phase)
0.6646 Remote Similarity NPD6002 Phase 3
0.6629 Remote Similarity NPD7075 Discontinued
0.6629 Remote Similarity NPD3926 Phase 2
0.6628 Remote Similarity NPD7411 Suspended
0.6627 Remote Similarity NPD6398 Clinical (unspecified phase)
0.6627 Remote Similarity NPD4109 Clinical (unspecified phase)
0.6627 Remote Similarity NPD4110 Phase 3
0.6607 Remote Similarity NPD6143 Clinical (unspecified phase)
0.659 Remote Similarity NPD6801 Discontinued
0.6587 Remote Similarity NPD3887 Approved
0.6581 Remote Similarity NPD1608 Approved
0.6571 Remote Similarity NPD4967 Phase 2
0.6571 Remote Similarity NPD4868 Clinical (unspecified phase)
0.6571 Remote Similarity NPD4966 Approved
0.6571 Remote Similarity NPD4965 Approved
0.6571 Remote Similarity NPD3882 Suspended
0.657 Remote Similarity NPD7028 Phase 2
0.6568 Remote Similarity NPD2532 Approved
0.6568 Remote Similarity NPD2534 Approved
0.6568 Remote Similarity NPD2533 Approved
0.6561 Remote Similarity NPD3266 Approved
0.6561 Remote Similarity NPD3267 Approved
0.6561 Remote Similarity NPD1049 Clinical (unspecified phase)
0.6548 Remote Similarity NPD7236 Approved
0.6545 Remote Similarity NPD5763 Approved
0.6545 Remote Similarity NPD5762 Approved
0.6545 Remote Similarity NPD2346 Discontinued
0.6545 Remote Similarity NPD2344 Approved
0.6543 Remote Similarity NPD6355 Discontinued
0.6535 Remote Similarity NPD8404 Phase 2
0.6534 Remote Similarity NPD3749 Approved
0.6527 Remote Similarity NPD3750 Approved
0.6517 Remote Similarity NPD7199 Phase 2
0.6514 Remote Similarity NPD3817 Phase 2
0.6514 Remote Similarity NPD5616 Clinical (unspecified phase)
0.6514 Remote Similarity NPD8443 Clinical (unspecified phase)
0.6497 Remote Similarity NPD1876 Approved
0.6497 Remote Similarity NPD6234 Discontinued
0.6494 Remote Similarity NPD3412 Clinical (unspecified phase)
0.6485 Remote Similarity NPD2438 Suspended
0.6481 Remote Similarity NPD4140 Approved
0.6467 Remote Similarity NPD1241 Discontinued
0.6467 Remote Similarity NPD2800 Approved
0.6464 Remote Similarity NPD7473 Discontinued
0.646 Remote Similarity NPD3268 Approved
0.6457 Remote Similarity NPD2393 Clinical (unspecified phase)
0.6444 Remote Similarity NPD7184 Clinical (unspecified phase)
0.6438 Remote Similarity NPD6832 Phase 2
0.6437 Remote Similarity NPD6386 Approved
0.6437 Remote Similarity NPD6385 Approved
0.6429 Remote Similarity NPD2163 Approved
0.6429 Remote Similarity NPD3818 Discontinued
0.6429 Remote Similarity NPD7003 Approved
0.6429 Remote Similarity NPD7799 Discontinued
0.6416 Remote Similarity NPD5808 Clinical (unspecified phase)
0.6415 Remote Similarity NPD5647 Approved
0.6409 Remote Similarity NPD2403 Approved
0.6409 Remote Similarity NPD7852 Clinical (unspecified phase)
0.6407 Remote Similarity NPD970 Clinical (unspecified phase)
0.64 Remote Similarity NPD37 Approved
0.64 Remote Similarity NPD1934 Approved
0.6391 Remote Similarity NPD2309 Approved
0.6389 Remote Similarity NPD6232 Discontinued
0.6387 Remote Similarity NPD1778 Approved
0.6386 Remote Similarity NPD1551 Phase 2
0.638 Remote Similarity NPD2979 Phase 3
0.6378 Remote Similarity NPD3057 Approved
0.6376 Remote Similarity NPD2181 Clinical (unspecified phase)
0.6358 Remote Similarity NPD7239 Suspended
0.6358 Remote Similarity NPD2313 Discontinued
0.6358 Remote Similarity NPD6859 Clinical (unspecified phase)
0.6358 Remote Similarity NPD3764 Approved
0.6353 Remote Similarity NPD6652 Clinical (unspecified phase)
0.6347 Remote Similarity NPD2355 Clinical (unspecified phase)
0.6347 Remote Similarity NPD2353 Approved
0.6345 Remote Similarity NPD7497 Discontinued
0.6337 Remote Similarity NPD7314 Clinical (unspecified phase)
0.6331 Remote Similarity NPD8166 Discontinued
0.6329 Remote Similarity NPD5327 Phase 3
0.6328 Remote Similarity NPD5402 Approved
0.6328 Remote Similarity NPD5353 Approved
0.6323 Remote Similarity NPD5585 Approved
0.6323 Remote Similarity NPD5691 Approved
0.6316 Remote Similarity NPD8397 Clinical (unspecified phase)
0.6312 Remote Similarity NPD6007 Clinical (unspecified phase)
0.631 Remote Similarity NPD1549 Phase 2
0.631 Remote Similarity NPD8312 Approved
0.631 Remote Similarity NPD8313 Approved
0.6307 Remote Similarity NPD6280 Approved
0.6307 Remote Similarity NPD6279 Approved
0.6306 Remote Similarity NPD1281 Approved
0.6306 Remote Similarity NPD1547 Clinical (unspecified phase)
0.6301 Remote Similarity NPD5403 Approved
0.6296 Remote Similarity NPD5952 Clinical (unspecified phase)
0.6294 Remote Similarity NPD3533 Approved
0.6294 Remote Similarity NPD2972 Approved
0.6293 Remote Similarity NPD5980 Discovery
0.629 Remote Similarity NPD7685 Pre-registration
0.6287 Remote Similarity NPD6100 Approved
0.6287 Remote Similarity NPD6099 Approved
0.6286 Remote Similarity NPD4380 Phase 2
0.628 Remote Similarity NPD4307 Phase 2
0.6279 Remote Similarity NPD4378 Clinical (unspecified phase)
0.6279 Remote Similarity NPD5401 Approved
0.6273 Remote Similarity NPD9494 Approved
0.6271 Remote Similarity NPD2801 Approved
0.6264 Remote Similarity NPD5242 Approved
0.6258 Remote Similarity NPD9545 Approved
0.6258 Remote Similarity NPD6798 Discontinued
0.6257 Remote Similarity NPD4381 Clinical (unspecified phase)
0.625 Remote Similarity NPD7177 Discontinued
0.625 Remote Similarity NPD1550 Clinical (unspecified phase)
0.625 Remote Similarity NPD7228 Approved
0.625 Remote Similarity NPD6873 Phase 2
0.625 Remote Similarity NPD1552 Clinical (unspecified phase)
0.6242 Remote Similarity NPD1933 Approved
0.6242 Remote Similarity NPD1899 Clinical (unspecified phase)
0.6242 Remote Similarity NPD5735 Approved
0.6242 Remote Similarity NPD447 Suspended
0.6237 Remote Similarity NPD7993 Clinical (unspecified phase)
0.623 Remote Similarity NPD4575 Clinical (unspecified phase)
0.6228 Remote Similarity NPD7033 Discontinued
0.622 Remote Similarity NPD6663 Approved
0.6212 Remote Similarity NPD2491 Approved
0.6211 Remote Similarity NPD2798 Approved
0.6209 Remote Similarity NPD7315 Approved
0.6209 Remote Similarity NPD7229 Phase 3
0.6205 Remote Similarity NPD6653 Approved
0.6201 Remote Similarity NPD7768 Phase 2
0.6199 Remote Similarity NPD2354 Approved
0.619 Remote Similarity NPD2531 Phase 2
0.619 Remote Similarity NPD2935 Discontinued
0.6188 Remote Similarity NPD1283 Approved
0.6185 Remote Similarity NPD3146 Approved
0.6185 Remote Similarity NPD3688 Clinical (unspecified phase)
0.6182 Remote Similarity NPD3140 Approved
0.6182 Remote Similarity NPD4060 Phase 1
0.6182 Remote Similarity NPD3142 Approved
0.618 Remote Similarity NPD1465 Phase 2
0.6178 Remote Similarity NPD6040 Clinical (unspecified phase)
0.6166 Remote Similarity NPD7879 Clinical (unspecified phase)
0.6159 Remote Similarity NPD1699 Clinical (unspecified phase)
0.6154 Remote Similarity NPD6959 Discontinued
0.6149 Remote Similarity NPD2797 Approved
0.6145 Remote Similarity NPD5978 Approved
0.6145 Remote Similarity NPD230 Phase 1
0.6145 Remote Similarity NPD5977 Approved
0.6142 Remote Similarity NPD8285 Discontinued
0.6141 Remote Similarity NPD6168 Clinical (unspecified phase)
0.6141 Remote Similarity NPD6167 Clinical (unspecified phase)
0.6141 Remote Similarity NPD6166 Phase 2
0.6141 Remote Similarity NPD4481 Phase 3
0.614 Remote Similarity NPD1878 Clinical (unspecified phase)
0.6139 Remote Similarity NPD7457 Clinical (unspecified phase)

  Bioactivity similarity: Similar Natural Products in NPASS

Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.

Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data